Can an arthritis drug help clear HIV from the brain?
Disease control
Recruiting now
This Phase 2 trial tests whether baricitinib, an FDA-approved arthritis drug, can reduce the amount of HIV hiding in the central nervous system. 95 people with HIV on stable antiretroviral therapy will receive either baricitinib or a placebo for 10 weeks. Researchers will measure…
Phase: PHASE2 • Sponsor: William Tyor • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC